NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
Back to search
Official data from USPTO
SELFTACS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SELFTACS
ST13
US500000098583034Class
1, 5, 9, 10, 42, 44
Filing
98583034
Registration
7896764
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
08/19/2025
Trademark type
Word
Nice classes
1, 5, 9, 10, 42, 44
Filing date
06/04/2024
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
24
Owner location
London, GB
Examiner
MOLINOFF, JEFFREY S.
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Kesmalea Therapeutics Limited
Representatives
Stacy J. Grossman Law Office of Stacy J. Grossman PLLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Proteins for use in science; regulatory protein arrays for scientific and medical use
Class 5
Pharmaceutical preparations for oncologyimmunologyviral infectionscentral nervous diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for the treatment of central nervous system diseases; biological preparations for medical use for the treatment of cancerautoimmune diseasesviral infectionscentral nervous diseases; Pharmaceutical preparations for the treatment of cancerviral infectionsautoimmune diseases and central nervous diseases; reagents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical use; protein synthesis inhibitors in the nature of antibioticsnone of the foregoing relating to preparations for the treatment of central nervous system diseases and disorders
Class 9
Scientific apparatus being spectrometers and parts and fittings thereforresearch apparatus being nuclear medical research imaging apparatusnavigation apparatus being on-board computers for vehiclessurveying apparatusphotographic apparatus being camerascinematographic camerasaudiovisual receiversoptical readersweighing machineslaser measuring systemssignalling whistlesradiation detecting apparatusplastic testing machinescameras for monitoring and inspecting equipmentlife-saving raftsteaching apparatus and instrumentsartificial limbs for medical instruction purposes; recorded computer operating software; recorded computer operating software for use in scientific and pharmaceutical research and development; recorded computer software for scientific modelling; recorded computer software for pharmaceutical modelling; recorded computer software for data analysis and conducting research and development in the field of oncologyimmunology and central nervous system disease; recorded computer software for the managinganalysisvisualisation of biological data; devices for analysing protein sequence used as laboratory apparatuslaboratory devices for detecting genetic sequences
Class 10
Surgical apparatus and instruments and medical imaging apparatus; medical devices for treatment of cancerautoimmune diseasesviral infections and central nervous diseases; apparatus for drug administrationdisposable syringes; medical diagnostic apparatus for the detection of abnormal prion protein
Class 42
Scientific laboratory servicesmedical research laboratory services; research relating to molecular sciences; blood analysis in the field of molecular biology for scientific research purposes; drug discovery services; clinical surgery research; medical research; biological research; medical research relating to pharmaceuticals; pharmaceutical research and development; development of pharmaceutical preparations and medicines; platform as a service (PaaS) featuring computer software platforms for data analysis; platform as a service (PaaS) featuring software platforms for medical analysis; software as a service (Saas) featuring software for assessing and storing patient information; provision of temporary use of onlinenon-downloadable software for the managementvisualisation and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; biotechnology research; scientific research and development in the pharmaceutical and biotechnology fields; chemical analysis; chemical research; medical research in the field of oncologyimmunology and central nervous system diseases; research and development in the field of protein homeostasis; scientific research in the nature of conducting clinical trials for others
Class 44
Medical services; medical analysis services relating to the treatment of patients; oral medical care services; medical diagnostic services; diagnostic and prognostic medical services; medical advisory services; medical screening; medical services in the field of oncology and immunotherapy; pharmacy adviceprescription refill reminder services; medical and health clinic services relating to antibodiesimmuno-oncologyinflammationhaematologycentral nervous system and infectious disease
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/03/2025
PUBO
PUBLISHED FOR OPPOSITION
06/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/28/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/22/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
04/22/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/22/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
04/22/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/22/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/25/2025
GNFR
FINAL REFUSAL E-MAILED
02/25/2025
CNFR
FINAL REFUSAL WRITTEN
02/25/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/06/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/20/2024
GNRT
NON-FINAL ACTION E-MAILED
12/20/2024
CNRT
NON-FINAL ACTION WRITTEN
12/20/2024
DOCK
ASSIGNED TO EXAMINER
12/16/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/15/2024
NWAP
NEW APPLICATION ENTERED
06/04/2024
Continuous trademark protection
Get notified about every new filing that threatens SELFTACS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.